Hip Replacement Arthroplasty
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
MedactaSwitzerland - Castel San Pietro
1 programAMIStem-H Radiological AssessmentN/A1 trial
Active Trials
Arcus BiosciencesHAYWARD, CA
1 programDetermination of Metal Ion Serum Levels and Cytokines in Total Hip ReplacementN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
MedactaAMIStem-H Radiological Assessment
Arcus BiosciencesDetermination of Metal Ion Serum Levels and Cytokines in Total Hip Replacement
Clinical Trials (2)
AMIStem-H Radiological Assessment
Start: Oct 2013Est. completion: Aug 2025
N/ATerminated
NCT01394744Arcus BiosciencesDetermination of Metal Ion Serum Levels and Cytokines in Total Hip Replacement
Determination of Metal Ion Serum Levels and Cytokines in Total Hip Replacement
Start: Aug 2011Est. completion: Feb 2019
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space